- New antiplatelet and anticoagulant drugs. Diabetic foot syndrome2008 | First Faculty of Medicine
- Inhibition of adhesion breast cancer cells by anticoagulant drugs and cimetidine2003 | Third Faculty of Medicine, Central Library of Charles University
- New anticoagulation drugs - a revolution in the prevention of thromeboembolic complications in atrial fibrillation2013 | First Faculty of Medicine
- Anticoagulant drugs increase natural killer cell activity in lung cancer2005 | Third Faculty of Medicine
- Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment +1Publication without faculty affiliation
- Patterns in anticoagulant utilization in the Czech Republic during 2007-20172019 | Faculty of Pharmacy in Hradec Králové
- Intravenous antithrombotics and trombolytic drugs2014 | Publication without faculty affiliation
- Edoxaban for treatment of venous thromboembolism in patients with cancer Rationale and design of the Hokusai VTE-cancer study2015 | Second Faculty of Medicine
- Budd-Chiari syndrome and polycythaemia vera - case report and discussion about anticoagulant therapy2018 | Faculty of Medicine in Pilsen
- Protocols of antithrombotic therapy in a University Cardiocenter2013 | Third Faculty of Medicine
- Garlic - possible interaction with other drugs +12007 | Publication without faculty affiliation
- Apixaban (Eliquis) for prevention of thromboembolic events in patients with atril fibrillation2012 | First Faculty of Medicine
- New anticoagulants in the prevention and treatment of cardiovascular diseases2010 | First Faculty of Medicine, Third Faculty of Medicine
- Anticoagulant and fibrinolytic drugs - possible agents in treatment of lung cancer?2012 | Third Faculty of Medicine
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- COST action B25 - Physiologically based pharmaco-toxico-kinetics and dynamics: expert meeting on "From models to individual patients" (from in silico to bedside)Publication without faculty affiliation
- Current approaches in preventing venous thromboembolism recurrence2019 | Faculty of Medicine in Pilsen
- Failure of Warfarin Anticoagulation Therapy after Administration of Oral Terbinafine2021 | Third Faculty of Medicine
- Antitumor and antimetastatic effect of warfarin and heparins2004 | Third Faculty of Medicine
- Rivaroxaban in atrial fibrillation2014 | Second Faculty of Medicine
- Rivaroxaban - metabolism, pharmacologic properties and drug interactions2019 | First Faculty of Medicine
- Evolution of deep vein thrombosis treatment from leeches to mechanical thrombectomy2022 | Faculty of Medicine in Hradec Králové
- Prevention and treatment of thromboembolic disease 20112011 | Third Faculty of Medicine, Central Library of Charles University
- Choosing patients for NOAC treatment: what to take into account?2015 | First Faculty of Medicine, Third Faculty of Medicine
- Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)2017 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové